AT

Regional & Special Circulations

Physiology · CVS · lean revision notes

Regional & Special Circulations

Each vascular bed serves an organ with unique metabolic and mechanical demands, so blood flow is governed by regional autoregulation layered on top of systemic neurohumoral control. This note covers coronary, cerebral, pulmonary, renal, splanchnic, skeletal-muscle, cutaneous and foetal circulations, with the autoregulatory mechanisms and exam-favourite phenomena that NEET PG repeatedly tests.

Core concepts: autoregulation & flow determinants

Autoregulation = the intrinsic ability of an organ to maintain near-constant blood flow despite changes in perfusion pressure (mean arterial pressure, MAP). Two competing theories explain it:

  1. Myogenic theory (Bayliss effect): vascular smooth muscle contracts when stretched. ↑ Transmural pressure → stretch → opening of stretch-activated cation channels → depolarisation → Ca²⁺ entry → vasoconstriction → flow normalised. This is the dominant mechanism in cerebral and renal beds.
  2. Metabolic theory: accumulation of vasodilator metabolites (adenosine, CO₂/H⁺, K⁺, lactate, ↓O₂) when flow falls below demand → vasodilatation → flow restored. Dominant in coronary and skeletal muscle.

High-yield: Flow through any vessel obeys Poiseuille's law — flow ∝ (ΔP × r⁴) / (η × L). Radius to the fourth power dominates, so small changes in vessel calibre cause large changes in flow. Resistance is therefore the controlled variable.

A complementary mechanism is flow-mediated (endothelial) dilatation: ↑ shear stress → endothelial NO (via eNOS) release → smooth-muscle relaxation. Other endothelial mediators: prostacyclin (PGI₂, vasodilator), endothelin-1 (potent vasoconstrictor), EDHF.

Vasodilators Vasoconstrictors
Adenosine, CO₂/H⁺, K⁺, lactate, hypoxia, NO, PGI₂, bradykinin, ANP, histamine Endothelin-1, angiotensin II, vasopressin, noradrenaline (α₁), thromboxane A₂, serotonin (most beds), hypoxia in the lung

Coronary circulation

The myocardium extracts 70–80 % of delivered O₂ at rest (the highest of any organ; coronary sinus O₂ saturation ≈ 30 %). Because extraction reserve is minimal, increased myocardial O₂ demand is met almost entirely by increased flow, which can rise 4–5 fold (coronary flow reserve).

Phasic flow: Left coronary flow is maximal in early diastole and minimal during systole, because systolic intramyocardial tension compresses the intramural (especially subendocardial) vessels. The subendocardium is therefore the most vulnerable to ischaemia. Right coronary flow is more uniform (lower RV systolic pressure).

High-yield: Coronary perfusion pressure ≈ aortic diastolic pressure − LV end-diastolic pressure (LVEDP). Tachycardia (shorter diastole) and ↑LVEDP (failure, AS) both reduce subendocardial perfusion.

Metabolic control: the principal mediator linking O₂ demand to coronary dilatation is adenosine (from ATP breakdown), with NO and K⁺ channel (K_ATP) opening contributing. Sympathetic stimulation produces net dilatation because the metabolic effect of ↑contractility/rate overrides direct α-constriction (β₂ also dilates).

Coronary steal phenomenon: A pharmacological vasodilator (dipyridamole, adenosine, hydralazine) dilates normal resistance vessels. Vessels in an ischaemic territory are already maximally dilated by local metabolites, so they cannot dilate further. Blood is "stolen" away from the ischaemic zone to the normal zone, worsening ischaemia. This is the basis of pharmacological/vasodilator stress testing (adenosine/dipyridamole/regadenoson MPI).

High-yield: Dipyridamole and adenosine cause coronary steal → used to unmask ischaemia in stress imaging. Aminophylline reverses adenosine-induced effects.

Cerebral circulation

Brain receives ~15 % of cardiac output (~750 mL/min, ~50 mL/100 g/min) and consumes ~20 % of body O₂. It has essentially no anaerobic reserve, so flow constancy is critical.

Cerebral autoregulation keeps cerebral blood flow (CBF) constant over a MAP of roughly 60–160 mmHg (memorise these limits). Below 60 → flow falls → ischaemia/syncope; above 160 → autoregulation breaks → forced vasodilatation, BBB disruption → hypertensive encephalopathy/oedema. Chronic hypertension shifts the curve to the right (tolerates higher but not lower pressures).

Determinant Effect on CBF
↑ PaCO₂ (hypercapnia) Potent vasodilatation → ↑CBF (most powerful chemical regulator)
↓ PaCO₂ (hyperventilation) Vasoconstriction → ↓CBF (used transiently in ↑ICP)
PaO₂ < 50 mmHg Vasodilatation → ↑CBF
↑ Neuronal activity Local metabolic ↑CBF (basis of fMRI BOLD signal)

Cerebral perfusion pressure (CPP) = MAP − ICP (or CVP, whichever higher). Normal CPP 70–100 mmHg; target > 60 mmHg in head injury.

High-yield: PaCO₂ is the strongest regulator of cerebral vessels. Each 1 mmHg change in PaCO₂ alters CBF by ~2–4 %. CO₂ acts via perivascular pH (H⁺), not CO₂ per se.

Monro–Kellie doctrine: the cranium is a rigid box; the sum of brain + blood + CSF volume is constant. A rise in one must be offset by a fall in another or ICP rises. Cushing reflex (response to ↑ICP): hypertension + bradycardia + irregular respiration (Cushing's triad).

Pulmonary circulation

A low-pressure, low-resistance, high-compliance system. Pulmonary artery pressure ~25/8 mmHg (mean ~15 mmHg) versus systemic ~120/80.

Hypoxic pulmonary vasoconstriction (HPV): Unlike every other vascular bed, alveolar hypoxia causes vasoconstriction in the pulmonary circulation. This diverts blood from poorly ventilated alveoli to well-ventilated ones, optimising V/Q matching. Mediated by inhibition of O₂-sensitive K⁺ channels in pulmonary smooth muscle → depolarisation → Ca²⁺ entry.

High-yield: HPV is the only circulation where hypoxia → vasoconstriction. Generalised alveolar hypoxia (high altitude, COPD) causes diffuse HPV → pulmonary hypertension → cor pulmonale.

Recruitment and distension: as cardiac output (or pressure) rises, previously closed apical capillaries open (recruitment) and patent ones widen (distension), so pulmonary vascular resistance (PVR) falls — this protects against pulmonary hypertension during exercise.

West zones (gravity-dependent flow, upright lung):

Zone Pressure relationship Flow
Zone 1 (apex) P_Alveolar > P_arterial > P_venous No flow (only if PA low, e.g. haemorrhage/PPV)
Zone 2 (mid) P_arterial > P_Alveolar > P_venous Flow ∝ (Pa − P_Alv) — "waterfall/sluice"
Zone 3 (base) P_arterial > P_venous > P_Alveolar Continuous flow, ↑ with venous pressure

High-yield: Normal upright lung has no Zone 1; it appears only when alveolar pressure rises (positive-pressure ventilation, PEEP) or arterial pressure falls (haemorrhage). Blood flow is greatest at the base.

Renal circulation

Kidneys receive ~20–25 % of cardiac output for their excretory function, not metabolic need. Cortex is richly perfused; the medulla is relatively hypoxic (countercurrent O₂ shunting), making the medullary thick ascending limb most vulnerable to ischaemia (acute tubular necrosis).

Renal autoregulation maintains both RBF and GFR over MAP 80–180 mmHg via two mechanisms:

  1. Myogenic (Bayliss) response of the afferent arteriole — fast.
  2. Tubuloglomerular feedback (TGF): macula densa senses ↑NaCl delivery → releases adenosine → afferent arteriolar constriction → ↓GFR (negative feedback). Conversely, low NaCl → renin release.

Angiotensin II preferentially constricts the efferent arteriole, preserving GFR (glomerular capillary pressure) when renal perfusion falls — hence ACE inhibitors/ARBs can drop GFR in bilateral renal artery stenosis. Prostaglandins (PGE₂, PGI₂) dilate the afferent arteriole and protect flow in hypovolaemia — NSAIDs blunt this and can precipitate AKI.

High-yield: Afferent dilatation (PGs) + efferent constriction (Ang II) both raise GFR. NSAIDs ↓afferent flow; ACEi/ARB ↓efferent tone — the classic "triple whammy" (ACEi + diuretic + NSAID) → AKI.

Skeletal muscle, cutaneous & splanchnic circulations

  • Skeletal muscle: at rest, high sympathetic tone keeps flow low; during exercise, local metabolites (K⁺, adenosine, CO₂, lactate, ↓O₂) cause active hyperaemia (flow can rise ~20-fold). Sympathetic cholinergic vasodilator fibres contribute to anticipatory vasodilatation.
  • Cutaneous: dominated by thermoregulation, not metabolism. Arteriovenous anastomoses (AVAs) (rich in glomus bodies, mostly sympathetic noradrenergic) shunt blood for heat loss/conservation. Cold → constriction; heat → dilatation + sweating (bradykinin from sweat glands).
  • Splanchnic: large blood reservoir; postprandial hyperaemia increases gut flow. Sympathetic stimulation (shock/exercise) markedly constricts it, mobilising blood centrally.

Reactive hyperaemia (after a period of occlusion) vs active hyperaemia (with ↑metabolism) — both are metabolically driven local responses; distinguish them in MCQs.

Foetal circulation

The placenta (not the lungs) is the organ of gas exchange; the lungs are fluid-filled and high-resistance, so blood is shunted away from the lungs through three shunts.

Flow path (oxygen-rich blood, bold arrows):

Placenta → umbilical vein (highest O₂, ~80 % sat) → ductus venosus (bypasses liver) → IVC → right atrium → foramen ovale → left atrium → LV → ascending aorta (head & coronaries get the best-oxygenated blood) → ... SVC/deoxygenated blood → RA → RV → pulmonary artery → ductus arteriosus → descending aorta → umbilical arteries → placenta.

Shunt Connects Becomes (adult remnant)
Ductus venosus Umbilical vein → IVC Ligamentum venosum
Foramen ovale RA → LA Fossa ovalis
Ductus arteriosus Pulmonary artery → aorta Ligamentum arteriosum
Umbilical vein Placenta → foetus Ligamentum teres (round ligament of liver)
Umbilical arteries Foetus → placenta Medial umbilical ligaments

Changes at birth (flow): First breath → lungs expand → alveolar O₂ ↑ → pulmonary vascular resistance falls → pulmonary flow ↑ → LA pressure rises. Cord clamping → systemic vascular resistance ↑. LA pressure > RA pressure → functional closure of foramen ovale. Rising PaO₂ + falling prostaglandins → ductus arteriosus constricts (functional closure 1–2 days; anatomical by ~3 weeks).

High-yield: Prostaglandin E₂ keeps the ductus arteriosus OPEN. To close a PDA give a prostaglandin synthesis inhibitor — indomethacin / ibuprofen (paracetamol is now also used). To keep it open in duct-dependent congenital heart disease, infuse PGE₁ (alprostadil).

High-yield: Highest oxygen saturation in the foetus is in the umbilical vein / ductus venosus; lowest is in the umbilical arteries / SVC.

Streaming: the crista dividens directs IVC blood preferentially across the foramen ovale, so the brain and myocardium receive the most oxygenated blood — a beautifully tested concept.

Complications & clinical correlates

  • Coronary steal → worsened angina with vasodilators; rationale of stress MPI.
  • Loss of cerebral autoregulation → hypertensive encephalopathy (above 160 mmHg) or watershed infarcts (below 60 mmHg, e.g. carotid stenosis + hypotension).
  • Chronic HPV → pulmonary hypertension, cor pulmonale; high-altitude pulmonary oedema (HAPE) from patchy HPV.
  • Renal: NSAID/ACEi-induced AKI; medullary ATN; renal artery stenosis with ACEi.
  • Persistent foetal shunts: PDA (machinery murmur), patent foramen ovale (paradoxical embolism), persistent pulmonary hypertension of the newborn (failure of PVR to fall).

Key differentials / "which circulation?" discriminators

Feature Unique to
Hypoxia → vasoconstriction Pulmonary circulation
Maximal flow in diastole Left coronary circulation
Resistance falls as flow rises (recruitment) Pulmonary circulation
Efferent arteriole as major regulator (Ang II) Renal circulation
Flow for thermoregulation via AV anastomoses Cutaneous circulation
Tubuloglomerular feedback via adenosine Renal circulation
Autoregulation 60–160 mmHg, CO₂-sensitive Cerebral circulation

Recently asked / exam angle

  • Coronary steal phenomenon — drug causing it (dipyridamole/adenosine/hydralazine) and its use in stress testing; why ischaemic vessels can't dilate further.
  • Cerebral autoregulation limits (60–160 mmHg) and the most potent regulator (PaCO₂ acting via H⁺).
  • Hypoxic pulmonary vasoconstriction — the "odd-one-out" circulation; mechanism (K⁺ channel inhibition) and consequence (cor pulmonale).
  • West zones — which zone has no flow, why Zone 1 appears with PPV/PEEP, where flow is maximal.
  • Foetal shunts and their remnants — match column questions; site of highest/lowest O₂ saturation.
  • Ductus arteriosus pharmacology — PGE₁ to keep open, indomethacin/ibuprofen to close; duct-dependent lesions.
  • Coronary O₂ extraction (70–80 %) and why demand is met by ↑flow not ↑extraction.
  • Renal — Ang II on efferent arteriole; NSAID + ACEi AKI; tubuloglomerular feedback mediated by adenosine.
  • Bayliss myogenic effect — definition and the beds where it predominates (renal, cerebral).
  • Coronary perfusion pressure = aortic diastolic − LVEDP; effect of tachycardia and aortic stenosis.

Rapid revision

  1. Bayliss myogenic effect: stretch of vascular smooth muscle → reflex vasoconstriction; basis of cerebral & renal autoregulation.
  2. Adenosine is the chief metabolic vasodilator of the coronary bed and the mediator of renal tubuloglomerular feedback.
  3. Myocardium extracts 70–80 % O₂ at rest → flow, not extraction, meets demand (coronary flow reserve 4–5×).
  4. Left coronary flow peaks in diastole; subendocardium is most ischaemia-prone; CPP = aortic diastolic − LVEDP.
  5. Coronary steal: vasodilators (dipyridamole, adenosine) divert blood from maximally dilated ischaemic zones — used in pharmacological stress imaging.
  6. Cerebral autoregulation: MAP 60–160 mmHg; chronic HTN shifts the curve rightward.
  7. PaCO₂ is the most powerful cerebral vasodilator; hyperventilation (↓CO₂) transiently lowers ICP.
  8. CPP = MAP − ICP; Monro–Kellie doctrine and Cushing triad (HTN + bradycardia + irregular breathing) with ↑ICP.
  9. Pulmonary circulation is the only bed where hypoxia → vasoconstriction (HPV), improving V/Q matching; chronic HPV → cor pulmonale.
  10. West Zone 1 (no flow) is abnormal — seen with PEEP/PPV or haemorrhage; flow is greatest at the base (Zone 3).
  11. Renal: Ang II constricts the efferent arteriole, prostaglandins dilate the afferent; NSAID + ACEi + diuretic = "triple whammy" AKI.
  12. Foetal: highest O₂ in umbilical vein/ductus venosus; PGE₁ keeps the ductus open, indomethacin/ibuprofen close it; remnants — ductus venosus → ligamentum venosum, ductus arteriosus → ligamentum arteriosum, foramen ovale → fossa ovalis.